 evalu ketotifen corticosteroid-depend idiopath anaphylaxi possibl efficaci ketotifen treatment idiopath anaphylaxi IA open-label trial patient IA corticosteroid dose diseas studi patient noncorticosteroid medic eg antihistamin oral adrenerg agent regular basi treatment IA studi period attempt corticosteroid dose reduct prednison dose continu control diseas evid benefici effect month administr patient probabl benefit reduct altern day prednison dose requir mg none mg mg mg none patient possibl benefit dose reduct mg mg patient unabl major decreas prednison symptom sign IA limit studi design efficaci treatment patient IA trial treatment IA